Search All News
Dr. Lourival Baptista-Neto speaks about CopeColumbia, where CUIMC employees can access psychological support and other support services.
Three CUIMC students have already put their naloxone training into action and saved the lives of strangers who had overdosed on opioids.
- June 6, 2016
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
- April 29, 2016
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
- April 19, 2016
Heavy cannabis use may alter the brain's dopamine system, revealing patterns of addiction commonly seen in other types of illicit drug use.
- April 11, 2016
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
- April 4, 2016
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
- March 31, 2016
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
- March 16, 2016
Researchers from Columbia and the National Institute on Alcohol Abuse and Alcoholism have found that the number of Americans with marijuana use disorder has nearly doubled, but few get treatment.
- March 11, 2016
Researchers have found that treatment with very low doses of a dopamine-1 receptor (D1R) agonist was not effective in reducing the cognitive and negative symptoms of schizophrenia.